These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 17897911)
21. [Effects of metalloproteinases-1 (TIMP-1) cDNA transfection on biological behaviors of PG cells]. Zhou KX; Wu BQ; Zheng J Zhonghua Yi Xue Za Zhi; 1994 Jul; 74(7):402-5, 454. PubMed ID: 7987710 [TBL] [Abstract][Full Text] [Related]
22. [Construction of an eukaryotic expression vector for PRL-2 and its effect on human hepatocellular carcinoma cell invasiveness and migration in vitro]. Ye HY; Guo AL; Zhang M; Lü GL; Wen JM Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):955-8. PubMed ID: 17666324 [TBL] [Abstract][Full Text] [Related]
23. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas. Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287 [TBL] [Abstract][Full Text] [Related]
24. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential. Liu F; Zhang Y; Zhang XY; Chen HL J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309 [TBL] [Abstract][Full Text] [Related]
25. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667 [TBL] [Abstract][Full Text] [Related]
26. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499 [TBL] [Abstract][Full Text] [Related]
27. [Influence of p16 gene on the biological behavior of human hepatocellular carcinoma]. Huang JZ; Xia SS; Ye QF; Jiang HY Ai Zheng; 2003 Jan; 22(1):46-9. PubMed ID: 12561435 [TBL] [Abstract][Full Text] [Related]
28. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486 [TBL] [Abstract][Full Text] [Related]
29. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119 [TBL] [Abstract][Full Text] [Related]
30. [Effect of exogenous expression of heparanase gene on invasive ability of colorectal cancer cell line HT29]. Liu Y; Ding YQ; Xin XY; Han LF; Liang L Ai Zheng; 2005 Dec; 24(12):1427-30. PubMed ID: 16351786 [TBL] [Abstract][Full Text] [Related]
31. Gene therapy of melanoma pulmonary metastasis by intramuscular injection of plasmid DNA encoding tissue inhibitor of metalloproteinases-1. Shi Y; Parhar RS; Zou M; Al-Mohanna FA; Paterson MC Cancer Gene Ther; 2002 Feb; 9(2):126-32. PubMed ID: 11857029 [TBL] [Abstract][Full Text] [Related]
32. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference]. Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Wang M; Liu YE; Greene J; Sheng S; Fuchs A; Rosen EM; Shi YE Oncogene; 1997 Jun; 14(23):2767-74. PubMed ID: 9190892 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. Ramer R; Hinz B J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069 [TBL] [Abstract][Full Text] [Related]
35. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960 [TBL] [Abstract][Full Text] [Related]
36. Involvement of RhoA in progression of human hepatocellular carcinoma. Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970 [TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Matsunaga Y; Koda M; Murawaki Y Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313 [TBL] [Abstract][Full Text] [Related]
38. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin. Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646 [TBL] [Abstract][Full Text] [Related]
39. Tissue inhibitor of metalloproteinase-2 inhibits ameloblastoma growth in a new mouse xenograft disease model. Zhang L; Zeng D; Huang H; Wang J; Tao Q; Pan C; Xu J; Zhang B; Wang A J Oral Pathol Med; 2010 Jan; 39(1):94-102. PubMed ID: 19895658 [TBL] [Abstract][Full Text] [Related]
40. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro. Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]